Home

Differential
Counter

Flow
Tutorial

 

 
 
Myeloproliferative
neoplasms
Neoplasms with eosinophilia
(PDGRA/PDGFRB/FGFR1)
MDS/MPN MDS AML Acute leukemia
ambiguous lineage
Precursor lymphoid
neoplasms
Mature B cell
neoplasms
Mature T and NK
neoplasms
Hodgkin
lymphoma
Immunodeficiency associated
lymphoproliferative disorders
Histiocytic and dendritic
cell neoplasms
 

Mantle Cell Lymphoma

  Unusual antigen expression abstracts Prognostic abstracts Cytogenetic abstracts Antigen chart
CLL/SLL
 B cell prolymphocytic leukemia
Splenic B cell marginal zone lymphoma
Hairy cell leukemia
Splenic B cell lymphoma / leukemia
Lymphoplasmacytic lymphoma
Heavy chain disease
Plasma cell neoplasms
Extranodal marginal zone lymphoma of mucosa associated lymphoid tissue
Nodal marginal zone lymphoma
Follicular lymphoma
Primary cutaneous follicle center lymhoma
Mantle cell lymphoma
Diffuse large B cell lymphoma
DLBCL associated with chronic inflammation
Lymphomatoid granulomatosis
Primary mediastinal large B cell lymphoma
Intravascular large B cell lymphoma
ALK positive large B cell lymphoma
Plasmablastic lymphoma
Large B cell lymphoma - HHV8 associated multicentric Castleman
Primary effusion lymphoma
Burkitt lymphoma
B cell lymphoma, unclassifiable with features of DLBCL and Burkitt
B cell lymphoma, unclassifiable with features of DLBCL and Hodgkin
Article Antigens evaluated
Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas. CD2, CD4, CD7, CD8
CD5- Mantle Cell Lymphoma CD5, Bcl-1, t(11;14)
B-cell lymphomas with coexpression of CD5 and CD10 CD5, CD10, Bcl-1, Bcl-6, CD43
An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10. CD5, CD10, CD19, CD20, CD23, t(11;14)-FISH
Aberrant immunophenotypes of mantle cell lymphomas. CD5, CD23
Assessment of CD10 in the diagnosis of small B-cell lymphomas: a multiparameter flow cytometric study. CD5, CD10
Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma. CD23
CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases. CD23
CD52 expression in mantle cell lymphoma. CD52
Aberrant expression and reverse signalling of CD70 on malignant B cells. CD27, CD40, CD70
Immunohistochemical detection of C-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in mantle cell lymphoma. CD117, VEGF, CD5, CD23, Bcl-1
Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. CyclinD1, CyclinD2, CyclinD3